1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate manufacturers
- L-tBuO-Pal-Glu(OSu)-OtBu
-
-
2026-07-24
- CAS:843666-26-2
- Min. Order: 1g
- Purity: 98%
- Supply Ability: 1g/bottle, 10g/bottle, 100g/bottle
|
| | 1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate Basic information |
| Product Name: | 1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate | | Synonyms: | 1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate;N-[16-(1,1-dimethylethoxy)-1,16-dioxohexadecyl]-L-Glutamic acid 1-(1,1-dimethylethyl) 5-(2,5-dioxo-1-pyrrolidinyl) ester;OtBu-Hexadecadioyl-L-Glu(OSu)-OtBu;Insulin Degludec Impurity 1;Deglutathin impurity 1;L-Glutamic acid, N-[16-(1,1-dimethylethoxy)-1,16-dioxohexadecyl]-, 1-(1,1-dimethylethyl) 5-(2,5-dioxo-1-pyrrolidinyl) ester;1-(1,1-Dimethylethyl) 5-(2,5-dioxo-1-pyrrolidinyl) N-[16-(1,1-dimethylethoxy)-1,16-dioxohexadecyl]-L-glutamate;Insulin Impurity 1 | | CAS: | 843666-26-2 | | MF: | C33H56N2O9 | | MW: | 624.81 | | EINECS: | | | Product Categories: | Degludec | | Mol File: | 843666-26-2.mol |  |
| | 1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate Chemical Properties |
| density | 1.11±0.1 g/cm3(Predicted) | | pka | 14.40±0.46(Predicted) | | InChIKey | OLPDHJKQJFDVHV-VWLOTQADSA-N | | SMILES | C(OC(C)(C)C)(=O)[C@H](CCC(ON1C(=O)CCC1=O)=O)NC(=O)CCCCCCCCCCCCCCC(OC(C)(C)C)=O |
| | 1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate Usage And Synthesis |
| Uses | 1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate is a carboxylic acid derivative and can be used as a pharmaceutical intermediate. |
| | 1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate Preparation Products And Raw materials |
|